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Background: In contrast to consistent epidemiologic evidence of the role of sexual transmission of human
papillomavirus (HPV) in adults, various routes may be related to HPV infection in infants. We have assessed
the extent of HPV infection during the perinatal period, and the relationship between mode of delivery and
vertical transmission.
Results: A total of 291 pregnant women over 36 weeks of gestation were enrolled with informed consent.
Exfoliative cells were collected from maternal cervix and neonatal buccal mucosa. HPV infection and genotypes
were determined with an HPV DNA chip, which can recognise 24 types. The HPV-positive neonates were
re-evaluated 6 months after birth to identify the presence of persistent infection. HPV DNA was detected in 18.9 %
(55/291) of pregnant women and 3.4 % (10/291) of neonates. Maternal infection was associated with abnormal
cytology (p = 0.007) and primiparity (p = 0.015). The infected neonates were all born to HPV-positive mothers.
The rate of vertical transmission was estimated at 18.2 % (10/55) which was positively correlated with maternal
multiple HPV infection (p = 0.003) and vaginal delivery (p = 0.050), but not with labour duration and premature
rupture of membranes. The rate of concordance of genotype was 100 % in mother-neonate pairs with vertical
transmission. The neonatal HPV DNAs found at birth were all cleared at 6 months after delivery.
Conclusions: Vertical transmission of HPV DNA from HPV infected mother to the neonate increased when the
infant was delivered through an infected cervix. However, the absence of persistent infection in infants at 6 months
after delivery may suggest temporary inoculation rather than true vertical infection.Background
Approximately 200 different genotypes of human papil-
lomavirus (HPV) have been identified and >40 types are
associated with anogenital diseases [1]. While these mu-
cosal types are suspected of affecting predominantly
adults, reports of HPV related diseases in the oropharyn-
geal and anogenital mucosa of infants and children born
to HPV infected mothers are increasing [2].* Correspondence: kimonc@hotmail.com
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reproduction in any medium, provided the orIn contrast to the consistent epidemiologic reports,
including the role of sexual transmission of HPV in adults
[3], potential routes of HPV infection from mother to
newborns were as follows: 1) during passage of the fetus
through an infected birth canal, 2) ascending infection
after premature rupture of the membranes, 3) infected
sperm at fertilization, and 4) hematogenous spread [4].
The extent and risk factors of HPV infections in in-
fants have been controversial. For pregnant women and
their babies, the only meta-analysis to date show that
vertical transmission developed in one-third of neonates
born to infected mothers mainly through vaginal deliv-
eries [5]. However, there was a wide variation in the rate
of vertical transmission ranging from 0-80 % [4,6–9].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics associated with maternal HPV
status
Characteristics HPV(+) (%) HPV(−) (%) P-value*
Age (y) ≤30 21 (24.4) 65 (75.6) 0.252
31-35 20 (15.4) 110 (84.6)
≥36 14 (18.7) 61 (81.3)
Gravida 1 25 (18.8) 108 (81.2) 0.803
2 20 (20.6) 77 (79.4)
≥3 10 (16.4) 51 (83.6)
Para 0 44 (22.9) 148 (77.1) 0.015
≥1 11 (11.1) 88 (88.9)
Abortion 0 31 (16.1) 161 (83.9) 0.095
≥1 24 (24.2) 75 (75.8)
Bacterial genital
infection
(−) 54 (18.8) 234 (81.3) 0.468
(+) 1 (33.3) 2 (66.7)
GDM (−) 55 (19.4) 229 (80.6) 0.354
(+) 0 (0.0) 7 (100.0)
Abnormal cytology (−) 50 (17.7) 233 (82.3) 0.007
(+) 5 (62.5) 3 (37.5)
GDM: gestational diabetes mellitus, *P< 0.05 indicates statistical significance
by a chi-square or Fisher’s exact test.
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reaction (PCR) or DNA sequencing has identified the lack
of concordance of HPV genotypes in 57-69 % of the
mother-neonate pairs [2]. The discrepancy is regarded as
evidence proposing various routes of viral transmission
other than the birth canal.
HPV DNA chip and PCR-based oligonucleotides mi-
croarray have been useful in many screening programs
for the early diagnosis of cervical dysplasia and cancer
[10]. This technique can accurately determine HPV-
positivity and distinguish types of HPV DNA, even in
cases infected with multiple types [11]. In addition to
potential factors associated with neonatal infection, HPV
genotying can be helpful in explaining the mechanism of
viral transmission.
In this study, we have determined the prevalence
of HPV infection in pregnant women and the rate of
vertical transmission during the perinatal period. The
risk factors associated with viral transmission were also
explored, including HPV genotypes.
Results
A total of 300 term pregnant women were enrolled
over the study period. Analyses were restricted to 291
women who gave birth in the institutes through vaginal
delivery (n = 193, 66.3 %) and caesarean section (n = 98,
33.7 %).
Maternal HPV status
The mean age of pregnant women was 32.8 years and
the prevalence of HPV infection was 18.9 % (55/291) in
maternal cervical swabs at enrolment determined by
means of HPV DNA chips. In the cytology performed
at the first trimester, 283 women were negative for
intraepithelial lesions and 8 had atypical squamous cells
of undetermined significance. Women with abnormal
cytology were referred for colposcopic examination and
the results indicated no dysplasia in the cervix. Prevalence
of HPV infection in the newborns was 3.4 % (10/291)
from swabs of oral mucosa at delivery.
Details of the maternal characteristics regarding age,
gestational history, bacterial genital infection, gestational
diabetes mellitus, and abnormal cytology are given in
Table 1. Women with primiparity (p = 0.015) or abnor-
mal cytology found at the first trimester (p = 0.007)
showed a higher prevalence of HPV infection in univar-
iate analyses with a chi-square or Fisher’s exact test.
These associations were not confounded by age, when
adjusted using the Mantel-Haenszel test for stratified
analysis. HPV infection was less frequent in multiparous
women (p = 0.034) and more in women with abnormal
cytology (p = 0.011), regardless of age.
Among the types specified by HPV DNA chip, HPV-
16 was the most frequent type in the maternal cervix(n = 55), comprising 8 cases (14.5 %) and other specified
HPV types were as follows: HPV-6, -56 each in 5 cases
(9.1 %); -53, -58, -70 each in 4 cases (7.3 %); -39, -40
each in 3 cases (5.5 %); and −44, -51, -31 each in 2 cases
(3.6 %). Each of HPV-11, -18, -33, -35, -45, and −66 was
noted only in one participant. HPV-other type, which
was positive in PCR but negative in HPV DNA chip, was
noted in 29.1 % (16/55). Genotyping showed that 58.2 %
(32/55) were infected with at least one type of high-
risk HPVs.
Co-infection with multiple genotypes was noted in
8 mothers; 3 mothers were infected with 3 types, and
5 with 2. HPV-53 (n=4) was the most frequent type found
in multiple infection. HPV-40 was detected in 3 cases and
HPV-44 and −56 were detected in 2 cases. HPV-11, -16,
-33, -35, -58, -66 and −68 were detected once.
Neonatal HPV status
At birth, HPV DNA was detected in 10 (3.4 %, 10/291)
neonates who were born to HPV-positive mothers.
There was no infection among infants born to HPV-
negative mothers. Therefore the overall frequency of
HPV transmission from HPV-positive mothers to their
infants was 18.2 % (10/55). Genotypes were concord-
ant in all of the mother-neonate pairs (Table 2). If one
type of HPV was identical among multiple types
detected in a mother neonate pair, the case was con-
sidered to be concordant. HPV-16 and HPV-53 were
the most frequent types and each was noted in 2
Table 2 Concordance of HPV genotypes in mother-
neonate pairs





4 11, 56 11 -
12 53, 66 53 -
13 40, 44, 53 40, 44, 53 -
42 35, 33 35 -
51 58, 31, 68 58 -
58 others Others -
113 56 56 -
151 16 16 -
177 16 16 -
201 6 6 -
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DNA chip tests repeated after 6 months from delivery
were negative.Factors associated with vertical transmission
To find out the reproductive characteristics contribut-
ing to vertical transmission of HPV, the pairs with
HPV-positive mothers were allocated into 2 groups
according to HPV status of newborns (Table 3). Neonates
had greater chances of acquiring infection when their
mothers were infected with multiple types (p= 0.003).
Among 10 infected newborns, all were delivered vaginally
and none by caesarean section. The difference was not
shown in terms of risk of HPV type, gestational age, birth
weight, and genital infection. Length of labour and statusTable 3 The reproductive characteristics associated with neon
Characteristics HPV(+)
Gestational age (w) 39.4
Weight (g) 3260
Genital infection (−) 10
(+) 0
Length of labour(min) (n = 45) 774
PROM (−) 6
(+) 4
Mode of delivery CS 0
VD 10
Risk of HPV type LR or other type 2
HR type 8
Number of HPV type Single 5
Multiple 5
SD: standard deviation, PROM: premature rupture of membranes, CS: caesarean sec
significance by a t-test* or a chi-square (or Fisher’s exact) test.of the amniotic membrane also showed the same values
between HPV-positive and HPV-negative newborns.
Discussion and conclusions
The prevalence and concordance of HPV infection in
mother neonate pairs by HPV genotype detection has
been investigated. Comparison of HPV genotypes in
relation to obstetric characteristics lead us to suggest the
primary route of vertical transmission during perinatal
period. According to epidemiological data of HPV infec-
tion in the female population, HPV prevalence ranges
from 10 % in women with normal cytology to nearly
100 % in women with cervical cancer [3,12,13]. In addition
to cervical disease, the age, region, HPV detection method
and study design are also associated with the estimates of
HPV infection [12].
For pregnant women, the percentage positivity varied
from 5.5 to 65 % using the only meta-analysis to date
[5]. Outstandingly high estimates tend to be reported by
research conducted in an endemic area or for high risk
participants identified with the pathos-mechanism of
vertical transmission. Up to 60 % of young pregnant
women were infected with HPV in Uganda, where a
similar frequency was reported in non-pregnant women
[14]. In contrast, a lower prevalence has been reported
by large cohort studies of the general population. A
recent study in Spain surveyed 828 women who were
consecutively included at the perinatal clinic and found
6.5 % to be infected with HPV [15]. A study by Taka-
kuwa et al. [16], one of the largest (n = 1183), presented
an overall prevalence of 12.5 %, with the prevalence in
women under 25 years of age being significantly higher
compared than in women over 25 years (22.6 vs. 11.3 %,
p< 0.0005).atal HPV status
(SD or %) HPV(−) (SD or %) P-value
(0.9) 39.5 (1.0) 0.791*
(304) 3306 (328) 0.958*
(18.5) 44 (81.5) 1.000
1
(424) 941 (622) 0.638*
(17.1) 29 (82.9) 1.000
(20.0) 16 (80.0)
(0.0) 14 (100.0) 0.050
(24.4) 31 (75.6)
(8.7) 21 (91.3) 0.166
(25.0) 24 (75.0)
(10.6) 42 (89.4) 0.003
(62.5) 3 (37.5)
tion, VD: vaginal delivery, LR: low risk, HR: high risk, P< 0.05 indicates statistical
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infection of the cervix to be 18.9 % in 291 Korean preg-
nant women without abnormal cervical lesion under col-
poscopy, which was comparable to those of large studies
mentioned above. The infection was more frequently
detected in women with abnormal cytology and without
a history of parturition. Although statistically insignifi-
cant, young women under 30 years of age were more
infected with HPV (Table 1).
Age is constantly reported to be related to the propor-
tion of positive findings in pregnant women, as in non-
pregnant women. Eppel et al. [17] showed decreased
prevalence of HPV infection with increasing maternal
age. The group younger than 30 years had twice the risk
risk of the group older than 30 years. In young women,
HPV infection is transient, which is considered to be
one of the mechanisms explaining why the finding of
HPV after the age of 25 or 30 years is less frequent [18].
Since Sedlacek et al. [5] detected HPV DNA in neo-
natal oropharyngeal aspirates [19], widely variable esti-
mates of perinatal HPV infection have been reported in
terms of neonatal prevalence, frequency of vertical trans-
mission, and persistent infection. Their inconsistent
results depend on selection criteria, sample size, period
of follow-up and particularly the method of assay.
A higher rate of vertical transmission, 70-80 %, came
from early small studies when analyzing methods for
HPV DNA detection by PCR were still developing [9,20].
While PCR is known to be the most sensitive method
and type-specific PCR can detect <10 copies of HPV
DNA, this technique can give false-positives due to con-
tamination, as it relies on a series of laboratory prepara-
tions for target amplification [21]. DNA sequencing,
another highly sensitive method, can verify the genotype
and reduce the probability of false-positives by sequenc-
ing. Smith et al. [6] were the first to sequence a number of
HPV genotypes and reported that only 3.7 % (6/164) of
neonates were positive for HPV DNA. However, this tech-
nique alone is unable to identify each viral type in multiple
infections.
In our study, vertical transmission was found in 18.5 %
(10/55) with HPV DNA chip, which can identify geno-
types even in the cases with multiple infections through
automated and efficient procedures. This technique is
appropriate for large epidemiological studies and its effi-
cacy for genotyping of HPV infection has been demon-
strated in cervical cancer screening programs [10,11].
Our results are supported by the fact that research since
2000 has reported similar estimates ranging from 10-
20 %, using strong laboratory methods that can genotype
a number of HPVs [15,22,23].
We could add some data to the current consensus that
HPV in a neonate was probably acquired during the pas-
sage through an infected cervix [5]. The genotypes wereconcordant in the mother newborn pairs with vertical
transmission that made us infer the source of HPV
infection (Table 2). In addition, 10 newborns with positive
HPV were delivered vaginally (Table 3). Tenti et al. [8]
reported very similar data that HPV DNA was positive
only in babies delivered through the infected birth canal,
and that the genotypes of the pairs were identical to
each other.
However, many studies also presented biological evi-
dence suggesting other possible routes of viral transmis-
sion. HPV DNAs have been detected in sperm, amniotic
fluid, placenta, cord and maternal blood [24–26]. Fur-
ther, the concordance of HPV types between mothers
and newborns is 57-69 % and HPV-positive newborns
having HPV-negative mothers have been reported [2].
These results propose that some newborns can acquire
HPV DNA through horizontal transmission from other
contact after birth or in uterine transmission at an
untested interval during early pregnancy.
In pregnant women, a few studies have assessed the
extent of multiple infections, which is considered un-
common. With the introduction of laboratory tech-
niques that can simultaneously identify multiple types of
HPV, some investigators have reported that co-infection
was detected in 17-66 % of the infected women
[15,22,23]. Several studies have attempted to picture the
association of multiple infections with vertical transmis-
sion. Tseng et al. [27] could distinguish only 2 types
(HPV-16, -18) with PCR and reported that vertical trans-
mission developed in 4 out of 11 women with double
infection and 23 out of 57 with single infections.
Rombaldi et al. [23] used the novel nested multiplex
PCR with an ability to differentiate 19 types and showed
that each 4 cases of vertical transmission occurred in 19
pairs with single infection and 30 with multiple infections.
In this report, we demonstrated that multiple infection
had a significantly higher probability of transmitting to
newborns than a single infection (5/8 vs. 5/47, p = 0.003)
(Table 3).
It has been argued whether or not the detection of
HPV DNA after birth reflects a true infection or con-
tamination. Because HPV infection has a long latent
period, the repeated detection of HPV in the same area
is considered as persistent infection. Some early studies
used PCR and serially detected HPV DNA in the buccal
and genital swabs at birth and at weeks to months of
postpartum. Cason et al. [9] demonstrated that HPV-16
DNA persisted for up to 6 months in 80 % of HPV posi-
tive infants at birth. Kaye et al. [28] showed HPV-16 in
the samples by sequencing analysis from 13 maternal
cervices, and from their infants at 6 weeks and 2 years
of age. The concordance was estimated to be 69.2 % and
at least 15.4 % of infants maintained maternally-derived
HPV infections until 2 years. In contrast to previous
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tion at 6 months in HPV positive newborns (Table 2).
A prospective study reported that the virus was cleared
in all infants as early as the 5th week during follow-up
period until 18 months [8]. In a cohort study of Finnish
families, the risk of infant HPV was not cervical HPV
during pregnancy, but persistent maternal HPV infection
[29]. These results indicate that vertical transmission
at birth may not contribute to persistent infection
in infants.
As commented in previous literature reviews, the esti-
mates should be interpreted with caution in respect of
geographic and demographic characteristics, research
design, and detection methods of HPV [2,5,12]. Because
our participants were consecutively included at one of
the largest obstetric clinics in Korea where over 5000
newborns are delivered in a year, our estimates are pre-
sumed to have credable generality. In order to ascertain
the persistency of HPV infection, we followed up the
infants until 6 month postpartum, which was scarcely
covered by previous studies [5,30]. We also discrimi-
nated over 24 HPV genotypes to evaluate the concor-
dance with DNA chip, which is the one of the largest
spectrums to date. Whilst HPV DNA chip is as efficient
as the existing HPV detection methods, a recent study
pointed out its limit of usefulness as a screening tool
due to low sensitivity [31]. The combined use of ad-
vanced diagnostic procedures will allow a more accurate
assessment of extent of HPV infection in pregnant
women and newborns in further studies [32].
In conclusion, the infection and transmission of HPV
was prevalent in pregnant women and their neonates.
We suggest that the perinatal transmission of HPV
takes place through an infected birth canal based on
the concordance of HPV genotypes and the predomi-
nance of vaginal delivery. However, the clearance of
HPV in all infants up to 6 months suggests that HPV
DNAs of newborns do not indicate persistent infection
in infants.
Methods
This prospective study was approved by the institu-
tion’s ethics committee. Near term pregnant women
anticipating deliveries at the department of obstetrics in
a university affiliated hospital were recruited between
April 2010 and January 2011. Participants fully under-
stood the protocol of this study and signed written con-
sent forms.
Study subjects
Pregnant women over 36 weeks gestation were included.
Exclusion criteria were as follows: severe intra-uterine
growth restriction, severe oligohydroamnios or preterm
premature rupture of membranes, severe hypertensionduring pregnancy, history of malignancies within 5 years,
liver cirrhosis, renal failure, chronic diseases affecting
maternofetal immunity and a history of psychological
disease and alcoholism. On the day of admission for
delivery, newborns of the participants were enrolled after
maternal re-consent.
At enrolment, cervical swabs were taken of the preg-
nant participants. Exfoliative cervical cells were collected
using cytobrush for HPV DNA chip analysis. Immedi-
ately after delivery, the oral mucosa of newborns was
scraped for HPV DNA chip analysis. The test was re-
peated at 6 month postpartum for HPV-positive infants
to identify persistent infection.
HPV DNA genotyping
HPV detection and genotyping was performed using the
HPV DNA Chip, PCR-based DNA microarray system,
purchased from MyGene Company (Seoul, South Korea).
The HPV DNA Chip contains 24 type specific probes;
15 types from the high-risk group (HPV-16, HPV-18,
HPV-31, HPV-33, HPV-35, HPV-39, HPV-45, HPV-51,
HPV-52, HPV-53, HPV-56, HPV-58, HPV-59, HPV-66,
and HPV-68) and 9 types from the low-risk groups
(HPV-6, HPV-11, HPV-34, HPV-40, HPV-42, HPV-43,
HPV-44, HPV-54, and HPV-70). Briefly, DNA was iso-
lated from swab samples using a DNA isolation kit (My
Gene. Co, Seoul, Korea), and target L1 regions of HPV
DNA were amplified using consensus GPd5+/GP6day +
primers. Ten μlof the HPV-amplified product was
denatured for 5 min at 95°C. The samples were mixed
with a hybridization solution then applied onto the DNA
Chip.
Hybridized HPV DNA was visualized using a DNA
Chip scanner (Scanarray lite; GSI LumonicsW, Ottawa,
Ontario, Canada). HPV amplicons can be hybridized with
the corresponding type-specific oligonucleotide probe and
visualized on HPV DNA Chip slides as double-positive
spots when HPV DNA is present in amplified PCR
product.
The samples that showed a positive band of 150 bp
on the gel electrophoresis, but were negative on the
HPV DNA Chip slide, were designated as HPV-other.
None of the negative controls (without DNA) revealed
HPV positivity.
Statistical analysis
To identify the factors associated with HPV infection in
pregnant women and neonates, participants were as-
signed into 2 groups according to the presence or ab-
sence of HPV. Continuous variables were compared
with Student’s t-test and discrete with chi-square test or
Fisher’s exact test. The Mantel-Haenszel test was used to
control for the confounding from age to some factors
which were significantly associated with maternal HPV
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significant with the use of a 2-sided test.
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